VNS Algorithm for Advanced Dosing
Recruiting
N/A
Interventional Study
Epilepsies
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 80 (estimated)
- Sponsor
- Fernando Vale · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to compare the standard programming of the VNS device (Control) to a modified programming (Augusta Way) in adults with epilepsy. The main question it aims to answer is:
Does the modified programming of the VNS reduce seizures faster than the standard programming?
Participants in both groups will:
1. Attend up to 3 study visits every 3 months for 2 years
2. Ans…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subjects who are clinically determined to be candidates for VNS implantation for seizure control
* Subject/legally authorized representative able to provide informed consent.
Exclusion Criteria:
* Subjects with VNS system treating pathologies other than drug refractory epile…
Contacts